Multiple Sclerosis

HBOT treatments have over a 30-year history of successfully treating Multiple Sclerosis patients. Studies show that both the tissue damage and symptoms of MS improve drastically following HBOT treatments for 70 to 80 percent of the patients! Patients who receive weekly treatment typically see the best results. Afterwards, periodic HBOT treatments reduce both the deterioration and the frequency of a relapse. While HBOT cannot help everyone with MS, it’s important to remember that even chronic MS patients have experienced dramatic
improvements.

When a person has Multiple Sclerosis, the brain tissues tend to swell and impede oxygen delivery. This can lead to loss of function. HBOT delivers 100% oxygen under pressure. The oxygen helps protect nerve cells from damage and maintains the integrity of the blood-brain barrier. It also allows the tissues to heal and restores the nervous system’s ability to accurately relay messages. HBOT treatments in the early stages of Multiple Sclerosis produce the best results. That’s because in the early stages the injured cells are dormant but viable, and the brain’s potential to restore lost function is greater.

Although there is no cure for Multiple Sclerosis, HBOT can help to slow the progression and treat the symptoms of the disease. Long-term benefits of HBOT for multiple sclerosis are very promising and can slow the spread of neurological damage as well as reduction of physical symptoms.

Many patients experience increased mobility and greater energy. Many have reduced urinary incontinence (the treatments help manage the MS bladder), less involuntary movements, and less fatigue symptoms.